Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) CFO Schond L. Greenway sold 5,652 shares of the company’s stock in a transaction on Tuesday, December 26th. The shares were sold at an average price of $3.63, for a total transaction of $20,516.76. Following the completion of the sale, the chief financial officer now directly […]
Mind Medicine (MindMed) (NASDAQ:MNMD – Get Free Report) is scheduled to be announcing its earnings results after the market closes on Thursday, November 2nd. Analysts expect the company to announce earnings of ($0.65) per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link. Mind […]
Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) have received an average recommendation of “Buy” from the eight research firms that are covering the company, Marketbeat.com reports. Eight research analysts have rated the stock with a buy rating. The average 1 year price objective among brokerages that have updated their coverage on […]
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) has been assigned a consensus rating of “Buy” from the eight brokerages that are currently covering the firm, Marketbeat reports. Eight equities research analysts have rated the stock with a buy rating. The average 12 month price target among brokerages that have issued a report on […]
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) CFO Schond L. Greenway sold 5,762 shares of the business’s stock in a transaction on Monday, September 25th. The stock was sold at an average price of $3.58, for a total value of $20,627.96. Following the transaction, the chief financial officer now owns 222,269 shares in […]